Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE
2012
REPORT TYPE
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERMedical University of South Carolina Charleston, SC 29425-0001
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTPatients that initially survi ve hemorrhage and resuscitation may develop a systemic infla mmatory response syndrome (SIRS) that lead s to injury and dysfun ction of vital orga ns (multiple organ dysfunction syndrome, MODS), particularl y to the liver and kidney. SIRS a nd MODS may involve m itochondrial dysfunction. Minocycline and doxycycline are tetracycline derivatives that are cytoprotective to liver, brain and other organs in various models of hypoxic, ischemic and oxidative stress, which may a ct by preserv ing mitochondrial function. We determined whether minocycline and doxycycline protect liver and kidney in a mouse model of hemorrhage and resuscitation. Minocycline and doxycycline each decreased liver enzymes and creatinine in the blood after hemorrhage/resuscitation compared to vehicle. Minocy cline and doxycycline also sig nificantly decreased liver necrosis and liver and kidney apoptosis. Lastly, minocycline protected against mitochondrial inner membrane permeabilization (mitochondrial permeability transition) occurring after HS/R and improved survival. In conclusion, minocycline and doxycycline when administered only after resu scitation decrease liver an d kidney injury a fter hemorrhage/resuscitation and improve survival. These safe and widely used agents mi ght be usefu l clinically to prevent SIRS and MODS after hemorrhagic shock. Despite improvements in evacuation, 35% of deaths from far forward battlefield injuries occur prior to arrival to a field hospital. Even after successful hemorrhagic resuscitation, late deaths from multiple organ failure occur in up to 50% of victims of severe multiple trauma...